David Dingli, MD, PhD | oneAMYLOIDOSISvoice
Healthcare Professionals

David Dingli, MD, PhD

Healthcare Professional
Department of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Dr. David Dingli is a hematology and internal medicine specialist at Mayo Clinic, Rochester, Minnesota and his clinical practice is devoted to patients with plasma cell disorders and chronic myeloid leukemia. He completed his Residency and Fellowship from Mayo Clinic College of Medicine. Dr. David Dingli pursued his PhD in molecular biology from Mayo Clinic College of Medicine and Science.

Dr. Dingli has experience in treating conditions like amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, paroxysmal nocturnal hemoglobinuria, plasma cell disorders, POEMS syndrome, Schnitzler syndrome, and Waldenstrom macroglobulinemia.


Representative Publications:

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method 

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma 

Natural history of multiple myeloma with de novo del(17p) 

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution 


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.